Araxes Pharma


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Araxes Pharma is developing first-in-class therapeutics against a certain target for the treatment of cancer.

Araxes Pharma is developing first-in-class therapeutics against a certain target for the treatment of cancer.

Company (Alive / Active)

Phone: 858-500-8800

Fax:

11119 N Torrey Pines Road
Suite 125
La Jolla, 92037
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Araxes Pharma $1M Nov 7, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Araxes Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Covalent inhibitors of k-ras g12c Nov 05, 2015 Mar 27, 2018 Patent
Inhibitors of kras g12c mutant proteins Sep 25, 2015 Jan 09, 2018 Patent
Substituted quinazolines as inhibitors of kras g12c Oct 10, 2014 Dec 12, 2017 Patent
Method for screening inhibitors of ras Nov 02, 2016 Nov 07, 2017 Patent
Irreversible covalent inhibitors of the gtpase k-ras g12c Mar 14, 2014 Aug 29, 2017 Patent
See all 16 patents